💊
İlaç Sektörü Hisseleri
İlaç Sektörü altında 485 Hisse Senedi
İlaç sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
485
Toplam Hisse
$3.2T
Toplam Piyasa Değeri
İlaç Sektörü Hisseleri
Sayfa 1/5 (Toplam: 485)
SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM | |
---|---|---|---|---|---|
LLY | Eli Lilly and Company | $680.94B | $737.67 | 2.09% | |
JNJ | Johnson & Johnson | $352.78B | $155.21 | 1.06% | |
ABBV | AbbVie Inc. | $332.08B | $186.11 | 0.26% | |
MRK | Merck & Co., Inc. | $187.27B | $76.84 | 0.58% | |
TMO | Thermo Fisher Scientific Inc. | $154.81B | $402.82 | 0.23% | |
AMGN | Amgen Inc. | $145.42B | $288.18 | 1.64% | |
PFE | Pfizer Inc. | $125.58B | $23.49 | 0.17% | |
GILD | Gilead Sciences, Inc. | $124.54B | $110.08 | 0.93% | |
VRTX | Vertex Pharmaceuticals Incorporated | $108.79B | $442.05 | 1.13% | |
BMY | Bristol-Myers Squibb Company | $94.81B | $48.28 | 0.90% | |
MCK | McKesson Corporation | $85.37B | $719.51 | 0.93% | |
CVS | CVS Health Corporation | $77.60B | $64.04 | 2.01% | |
ZTS | Zoetis Inc. | $68.82B | $168.63 | 0.89% | |
REGN | Regeneron Pharmaceuticals, Inc. | $60.44B | $490.28 | 19.01% | |
CAH | Cardinal Health, Inc. | $35.39B | $154.44 | 0.29% | |
ALNY | Alnylam Pharmaceuticals, Inc. | $34.80B | $304.56 | 3.98% | |
STE | STERIS plc | $22.36B | $245.21 | 0.09% | |
BIIB | Biogen Inc. | $18.05B | $129.79 | 2.23% | |
BAX | Baxter International Inc. | $15.99B | $30.50 | 0.64% | |
WST | West Pharmaceutical Services, Inc. | $14.97B | $210.85 | 0.19% | |
ITCI | Intra-Cellular Therapies, Inc. | $14.05B | $131.87 | 0.00% | |
HIMS | Hims & Hers Health, Inc. | $13.32B | $56.56 | 7.94% | |
EXEL | Exelixis, Inc. | $12.15B | $43.04 | 1.03% | |
INSM | Insmed Incorporated | $11.92B | $69.73 | 0.75% | |
NBIX | Neurocrine Biosciences, Inc. | $11.77B | $123.02 | 0.52% | |
INCY | Incyte Corporation | $11.72B | $65.06 | 1.48% | |
BMRN | BioMarin Pharmaceutical Inc. | $11.46B | $58.07 | 0.82% | |
VTRS | Viatris Inc. | $9.92B | $8.79 | 0.45% | |
WBA | Walgreens Boots Alliance, Inc. | $9.66B | $11.25 | 0.13% | |
MRNA | Moderna, Inc. | $9.46B | $26.56 | 1.37% | |
MEDP | Medpace Holdings, Inc. | $8.47B | $294.90 | 0.72% | |
CORT | Corcept Therapeutics Incorporated | $7.53B | $77.56 | 0.10% | |
RVMD | Revolution Medicines, Inc. | $7.37B | $39.40 | 0.81% | |
RGEN | Repligen Corporation | $7.19B | $118.07 | 3.47% | |
BPMC | Blueprint Medicines Corporation | $6.42B | $101.35 | 1.66% | |
ELAN | Elanco Animal Health Incorporated | $6.37B | $13.44 | 0.59% | |
MDGL | Madrigal Pharmaceuticals, Inc. | $6.33B | $275.26 | 1.97% | |
BBIO | BridgeBio Pharma, Inc. | $6.32B | $34.25 | 2.64% | |
HALO | Halozyme Therapeutics, Inc. | $6.06B | $56.07 | 2.45% | |
LNTH | Lantheus Holdings, Inc. | $5.40B | $75.56 | 0.05% | |
GKOS | Glaukos Corporation | $5.31B | $94.29 | 0.61% | |
TGTX | TG Therapeutics, Inc. | $5.30B | $35.11 | 1.68% | |
OPCH | Option Care Health, Inc. | $5.22B | $32.68 | 1.30% | |
AXSM | Axsome Therapeutics, Inc. | $5.20B | $105.16 | 0.50% | |
IONS | Ionis Pharmaceuticals, Inc. | $5.18B | $33.51 | 0.15% | |
NUVL | Nuvalent, Inc. | $5.07B | $74.61 | 0.20% | |
ADMA | ADMA Biologics, Inc. | $4.75B | $19.84 | 0.35% | |
PBH | Prestige Consumer Healthcare Inc. | $4.26B | $85.67 | 1.41% | |
PCVX | Vaxcyte, Inc. | $3.76B | $32.49 | 0.95% | |
PTCT | PTC Therapeutics, Inc. | $3.75B | $48.52 | 0.76% | |
KRYS | Krystal Biotech, Inc. | $3.72B | $125.96 | 0.28% | |
SLNO | Soleno Therapeutics, Inc. | $3.69B | $73.35 | 3.00% | |
CYTK | Cytokinetics, Incorporated | $3.64B | $31.02 | 0.96% | |
RYTM | Rhythm Pharmaceuticals, Inc. | $3.63B | $61.33 | 0.89% | |
SRPT | Sarepta Therapeutics, Inc. | $3.52B | $37.60 | 2.62% | |
AMRX | Amneal Pharmaceuticals, Inc. | $3.49B | $7.32 | 0.27% | |
SWTX | SpringWorks Therapeutics, Inc. | $3.48B | $46.71 | 0.06% | |
ICUI | ICU Medical, Inc. | $3.41B | $134.86 | 0.32% | |
RNA | Avidity Biosciences, Inc. | $3.40B | $30.98 | 2.27% | |
RARE | Ultragenyx Pharmaceutical Inc. | $3.27B | $34.03 | 2.85% | |
ACLX | Arcellx, Inc. | $3.21B | $62.06 | 2.54% | |
AKRO | Akero Therapeutics, Inc. | $3.19B | $49.65 | 3.37% | |
SRRK | Scholar Rock Holding Corporation | $2.93B | $29.01 | 2.78% | |
CPRX | Catalyst Pharmaceuticals, Inc. | $2.91B | $24.96 | 1.55% | |
CRNX | Crinetics Pharmaceuticals, Inc. | $2.90B | $30.51 | 0.03% | |
ACAD | ACADIA Pharmaceuticals Inc. | $2.88B | $21.57 | 3.23% | |
PTGX | Protagonist Therapeutics, Inc. | $2.68B | $47.47 | 0.23% | |
LEGN | Legend Biotech Corporation | $2.61B | $28.95 | 0.07% | |
IMVT | Immunovant, Inc. | $2.33B | $14.85 | 0.27% | |
APGE | Apogee Therapeutics, Inc. | $2.32B | $36.64 | 2.77% | |
QDEL | QuidelOrtho Corporation | $2.29B | $30.67 | 0.26% | |
IBRX | ImmunityBio, Inc. | $2.25B | $2.66 | 2.31% | |
MIRM | Mirum Pharmaceuticals, Inc. | $2.21B | $44.46 | 1.05% | |
APLS | Apellis Pharmaceuticals, Inc. | $2.17B | $16.93 | 2.76% | |
BCRX | BioCryst Pharmaceuticals, Inc. | $2.11B | $10.75 | 1.19% | |
OGN | Organon & Co. | $2.10B | $9.22 | 3.35% | |
ARWR | Arrowhead Pharmaceuticals, Inc. | $2.10B | $16.07 | 4.46% | |
DNLI | Denali Therapeutics Inc. | $2.05B | $13.24 | 2.22% | |
LGND | Ligand Pharmaceuticals Incorporated | $2.02B | $102.19 | 1.27% | |
BHVN | Biohaven Ltd. | $1.99B | $14.81 | 0.47% | |
CERT | Certara, Inc. | $1.97B | $11.36 | 0.35% | |
HRMY | Harmony Biosciences Holdings, Inc. | $1.97B | $34.50 | 1.32% | |
BLTE | Belite Bio, Inc | $1.94B | $64.87 | 1.17% | |
KYMR | Kymera Therapeutics, Inc. | $1.93B | $29.64 | 2.02% | |
TVTX | Travere Therapeutics, Inc. | $1.87B | $15.02 | 2.34% | |
FOLD | Amicus Therapeutics, Inc. | $1.86B | $6.07 | 2.25% | |
CGON | CG Oncology, Inc. Common stock | $1.85B | $25.62 | 2.33% | |
BEAM | Beam Therapeutics Inc. | $1.82B | $15.83 | 3.00% | |
TARS | Tarsus Pharmaceuticals, Inc. | $1.80B | $42.95 | 1.13% | |
SUPN | Supernus Pharmaceuticals, Inc. | $1.78B | $31.70 | 0.06% | |
RXRX | Recursion Pharmaceuticals, Inc. | $1.74B | $4.18 | 6.07% | |
SDGR | Schrödinger, Inc. | $1.73B | $21.62 | 0.84% | |
AGIO | Agios Pharmaceuticals, Inc. | $1.66B | $32.09 | 0.79% | |
ARQT | Arcutis Biotherapeutics, Inc. | $1.65B | $13.04 | 4.61% | |
IRON | Disc Medicine, Inc. | $1.58B | $46.68 | 0.41% | |
GDRX | GoodRx Holdings, Inc. | $1.55B | $3.92 | 2.89% | |
LQDA | Liquidia Corporation | $1.50B | $14.92 | 0.53% | |
IDYA | IDEAYA Biosciences, Inc. | $1.49B | $19.89 | 0.80% | |
MNKD | MannKind Corporation | $1.40B | $4.15 | 0.73% | |
INDV | Indivior PLC | $1.39B | $12.86 | 3.63% |